Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Lauric-acid | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Lauric-acid | hsa00071 | Fatty acid degradation | 4.87E-03 | 2 | P11310, P28332 | ACADM, ADH6 | More | | Lauric-acid | hsa00520 | Amino sugar and nucleotide sugar metabolism | 7.87E-03 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Lauric-acid | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Lauric-acid | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 4.30E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | | Lauric-acid | hsa01200 | Carbon metabolism | 4.06E-02 | 5 | P37837, O14521, P50213, P60891, Q02252 | TALDO1, SDHD, IDH3A, PRPS1, ALDH6A1 | More | | Lauric-acid | hsa01522 | Endocrine resistance | 3.67E-02 | 5 | P14780, P22694, Q9UM47, P46527, P10415 | MMP9, PRKACB, NOTCH3, CDKN1B, BCL2 | More | | Lauric-acid | hsa01523 | Antifolate resistance | 2.24E-02 | 3 | P41439, P41440, P01375 | FOLR3, SLC19A1, TNF | More | | Lauric-acid | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Lauric-acid | hsa03010 | Ribosome | 1.86E-02 | 2 | P46777, P50914 | RPL5, RPL14 | More | | Lauric-acid | hsa03013 | RNA transport | 6.87E-03 | 11 | P52298, Q09161, O14893, P61326, P37198, Q7Z3B4, P35658, Q14152, O75822, Q9Y6A5, Q06787 | NCBP2, NCBP1, GEMIN2, MAGOH, NUP62, NUP54, NUP214, EIF3A, EIF3J, TACC3, FMR1 | More | | Lauric-acid | hsa03015 | mRNA surveillance pathway | 3.71E-02 | 6 | O43148, Q13362, O94913, Q12996, Q09161, P52298 | RNMT, PPP2R5C, PCF11, CSTF3, NCBP1, NCBP2 | More | | Lauric-acid | hsa03020 | RNA polymerase | 3.00E-02 | 3 | P30876, P24928, P62487 | POLR2B, POLR2A, POLR2G | More | | Lauric-acid | hsa03060 | Protein export | 4.42E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Lauric-acid | hsa03320 | PPAR signaling pathway | 3.78E-02 | 2 | Q6PCB7, Q9UNU6 | SLC27A1, CYP8B1 | More | | Lauric-acid | hsa04071 | Sphingolipid signaling pathway | 1.94E-02 | 6 | Q9H228, P01375, Q13362, Q9BX95, P10415, Q9UQC2 | EDG8, TNF, PPP2R5C, SGPP1, BCL2, GAB2 | More | | Lauric-acid | hsa04114 | Oocyte meiosis | 4.51E-03 | 5 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | | Lauric-acid | hsa04137 | Mitophagy - animal | 3.24E-02 | 4 | Q96CV9, Q9H1Y0, P18848, O43524 | OPTN, ATG5, ATF4, FOXO3 | More | | Lauric-acid | hsa04141 | Protein processing in endoplasmic reticulum | 2.48E-02 | 4 | P30101, P60604, P08238, Q9H173 | PDIA3, UBE2G2, HSP90AB1, SIL1 | More | | Lauric-acid | hsa04142 | Lysosome | 1.46E-02 | 7 | P06865, P38571, Q13510, P07602, P61916, Q04900, Q9Y227 | HEXA, LIPA, ASAH1, PSAP, NPC2, CD164, ENTPD4 | More | | Lauric-acid | hsa04144 | Endocytosis | 1.38E-03 | 10 | P0DMV8, Q9H444, O75351, P62491, P42566, Q15438, Q14161, Q96QK1, Q9UMY4, Q9UNH7 | HSPA1A, CHMP4B, VPS4B, RAB11A, EPS15, PSCD1, GIT2, VPS35, SNX12, SNX6 | More | | Lauric-acid | hsa04217 | Necroptosis | 3.99E-02 | 6 | P23458, Q9NQC7, P01584, Q9BTM1, Q9H444, O75351 | JAK1, CYLD, IL1B, H2AFJ, CHMP4B, VPS4B | More | | Lauric-acid | hsa04260 | Cardiac muscle contraction | 4.78E-02 | 3 | P67936, P13073, P12074 | TPM4, COX4I1, COX6A1 | More | | Lauric-acid | hsa04340 | Hedgehog signaling pathway | 1.80E-02 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Lauric-acid | hsa04370 | VEGF signaling pathway | 2.47E-03 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | | Lauric-acid | hsa04514 | Cell adhesion molecules | 4.32E-02 | 3 | P13612, P11215, P01730 | ITGA4, ITGAM, CD4 | More | | Lauric-acid | hsa04610 | Complement and coagulation cascades | 4.02E-04 | 4 | P0C0L4, P12259, P20023, P11215 | C4A, F5, CR2, ITGAM | More | | Lauric-acid | hsa04613 | Neutrophil extracellular trap formation | 6.75E-04 | 15 | P17252, O60603, P05164, P08246, Q9UM07, Q92769, Q6FI13, P14598, Q15080, P49913, O75015, P21730, P21462, O43315, Q16539 | PRKCA, TLR2, MPO, ELA2, PADI4, HDAC2, H2AC18; H2AC19, NCF1, NCF4, CAMP, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Lauric-acid | hsa04621 | NOD-like receptor signaling pathway | 7.61E-03 | 10 | P25963, Q9H1Y0, O00463, P10415, Q05823, P01375, P49913, P59665, P59666, P12838 | NFKBIA, ATG5, TRAF5, BCL2, RNASEL, TNF, CAMP, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Lauric-acid | hsa04640 | Hematopoietic cell lineage | 1.01E-02 | 5 | P13612, P11215, P20023, P01730, P04141 | ITGA4, ITGAM, CR2, CD4, CSF2 | More | | Lauric-acid | hsa04650 | Natural killer cell mediated cytotoxicity | 2.87E-03 | 9 | P16298, P50591, P01375, Q02750, Q13241, P26718, O75015, P26717, P26715 | PPP3CB, TNFSF10, TNF, MAP2K1, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | | Lauric-acid | hsa04657 | IL-17 signaling pathway | 1.53E-02 | 6 | P25963, O00463, P14780, P80188, P01375, P06702 | NFKBIA, TRAF5, MMP9, LCN2, TNF, S100A9 | More | | Lauric-acid | hsa04662 | B cell receptor signaling pathway | 3.54E-02 | 3 | P25963, P20023, P07948 | NFKBIA, CR2, LYN | More | | Lauric-acid | hsa04664 | Fc epsilon RI signaling pathway | 1.23E-02 | 3 | P04141, P07948, P09917 | CSF2, LYN, ALOX5 | More | | Lauric-acid | hsa04710 | Circadian rhythm | 1.67E-02 | 2 | Q16526, Q9Y478 | CRY1, PRKAB1 | More | | Lauric-acid | hsa04720 | Long-term potentiation | 2.35E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | | Lauric-acid | hsa04912 | GnRH signaling pathway | 3.39E-02 | 4 | P17252, Q16539, Q9Y6R4, Q14643 | PRKCA, MAPK14, MAP3K4, ITPR1 | More | | Lauric-acid | hsa04914 | Progesterone-mediated oocyte maturation | 7.70E-03 | 4 | Q17RY0, Q9Y6D9, P51812, Q02750 | CPEB4, MAD1L1, RPS6KA3, MAP2K1 | More | | Lauric-acid | hsa04919 | Thyroid hormone signaling pathway | 4.77E-02 | 1 | O60244 | MED14 | More | | Lauric-acid | hsa04920 | Adipocytokine signaling pathway | 4.31E-02 | 2 | Q9Y478, Q96RR4 | PRKAB1, CAMKK2 | More | | Lauric-acid | hsa04924 | Renin secretion | 3.64E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Lauric-acid | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Lauric-acid | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Lauric-acid | hsa04972 | Pancreatic secretion | 3.86E-02 | 3 | Q14643, P20020, P17252 | ITPR1, ATP2B1, PRKCA | More | | Lauric-acid | hsa05016 | Huntington disease | 2.46E-02 | 9 | O95298, P13073, P12074, P24928, P30876, P62487, O75460, P28070, O00232 | NDUFC2, COX4I1, COX6A1, POLR2A, POLR2B, POLR2G, ERN1, PSMB4, PSMD12 | More | | Lauric-acid | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Lauric-acid | hsa05134 | Legionellosis | 2.82E-02 | 3 | P01584, Q9NR31, P0DMV8 | IL1B, SAR1A, HSPA1A | More | | Lauric-acid | hsa05135 | Yersinia infection | 2.58E-02 | 4 | Q05397, P51812, Q02750, Q96JJ3 | PTK2, RPS6KA3, MAP2K1, ELMO2 | More | | Lauric-acid | hsa05140 | Leishmaniasis | 2.04E-02 | 7 | O75015, P14598, O60603, P25963, P01375, P29350, Q15080 | FCGR3B, NCF1, TLR2, NFKBIA, TNF, PTPN6, NCF4 | More | | Lauric-acid | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Lauric-acid | hsa05144 | Malaria | 6.79E-03 | 6 | P69905, P68871, O60603, P01375, P35443, P26718 | HBA2, HBB, TLR2, TNF, THBS4, KLRK1 | More | | Lauric-acid | hsa05150 | Staphylococcus aureus infection | 3.71E-02 | 6 | P21462, O75015, P59665, P59666, P12838, P49913 | FPR1, FCGR3B, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | | Lauric-acid | hsa05152 | Tuberculosis | 3.04E-02 | 9 | Q13488, O75015, P48382, P25208, O60603, P01375, P10415, P49913, Q9UDY8 | TCIRG1, FCGR3B, RFX5, NFYB, TLR2, TNF, BCL2, CAMP, MALT1 | More | | Lauric-acid | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.33E-03 | 6 | P25963, P50151, O15123, P07948, P01106, P04141 | NFKBIA, GNG10, ANGPT2, LYN, MYC, CSF2 | More | | Lauric-acid | hsa05169 | Epstein-Barr virus infection | 4.73E-02 | 5 | P20023, P01106, P25963, P07948, P30101 | CR2, MYC, NFKBIA, LYN, PDIA3 | More | | Lauric-acid | hsa05170 | Human immunodeficiency virus 1 infection | 4.37E-02 | 4 | Q02750, P62879, P16298, Q05397 | MAP2K1, GNB2, PPP3CB, PTK2 | More | | Lauric-acid | hsa05202 | Transcriptional misregulation in cancer | 8.78E-03 | 10 | Q13315, P14780, P46527, P35226, O60583, P05164, P59665, P59666, P12838, P08246 | ATM, MMP9, CDKN1B, BMI1, CCNT2, MPO, DEFA1; DEFA1B, DEFA3, DEFA4, ELA2 | More | | Lauric-acid | hsa05203 | Viral carcinogenesis | 4.73E-02 | 4 | P07948, P25963, P62807, Q93079 | LYN, NFKBIA, HIST1H2BC, H2BC9 | More | | Lauric-acid | hsa05221 | Acute myeloid leukemia | 1.68E-02 | 3 | P01106, P11215, P04141 | MYC, ITGAM, CSF2 | More | | Lauric-acid | hsa05222 | Small cell lung cancer | 4.26E-02 | 6 | P10826, Q13489, P10415, Q13077, O00463, P24522 | RARB, BIRC3, BCL2, TRAF1, TRAF5, GADD45A | More | | Lauric-acid | hsa05321 | Inflammatory bowel disease | 4.92E-02 | 4 | O60603, P01375, Q14765, Q9UL17 | TLR2, TNF, STAT4, TBX21 | More | | Lauric-acid | hsa05332 | Graft-versus-host disease | 1.48E-03 | 4 | P10747, P01375, P26715, Q13241 | CD28, TNF, KLRC1, KLRD1 | More | | Lauric-acid | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Lauric-acid | hsa05415 | Diabetic cardiomyopathy | 3.19E-02 | 7 | P17252, P14598, Q15080, Q16718, O14521, Q16539, P14780 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, MAPK14, MMP9 | More | | |